Tressa Randall, Vice President Regulatory Affairs and Quality
Professional Overview
Tressa Randall is an experienced pharmaceutical executive serving as the Vice President of Regulatory Affairs and Quality at Faraday Pharmaceuticals, Inc. With over 15 years of industry expertise, she specializes in navigating complex regulatory landscapes and driving quality assurance initiatives to ensure the safe and effective development of pharmaceutical products.
Experience Summary
Current Role
As the Vice President of Regulatory Affairs and Quality at Faraday Pharmaceuticals, Tressa is responsible for leading the company's regulatory strategy and quality management programs. In this role, she oversees the preparation and submission of regulatory filings, coordinates with global health authorities, and ensures the organization's products and processes meet the highest quality standards. Tressa's leadership has been instrumental in securing several successful regulatory approvals and maintaining Faraday's strong reputation for product quality and compliance.
Career Progression
Prior to her current position, Tressa held various roles of increasing responsibility in the pharmaceutical industry. She served as the Director of Regulatory Affairs at Acme Pharmaceuticals, where she spearheaded the company's global regulatory strategy and managed complex product registrations across multiple markets. Earlier in her career, Tressa was a Regulatory Affairs Specialist at Apex Biotech, contributing to the successful launch of several innovative drug candidates.
Academic Background
Tressa holds a Bachelor of Science degree in Pharmaceutical Sciences from the University of Washington, where she graduated with honors. She also completed a Master of Business Administration (MBA) program, further enhancing her strategic and leadership capabilities in the pharmaceutical industry.
Areas of Expertise
- Regulatory affairs and compliance
- Quality assurance and control
- Global product registration and lifecycle management
- Pharmaceutical product development and commercialization
- Cross-functional team leadership and collaboration
Professional Impact
Tressa's expertise and strategic vision have been instrumental in driving Faraday Pharmaceuticals' regulatory and quality initiatives. Under her guidance, the company has successfully navigated complex regulatory landscapes, securing approvals for multiple product launches and maintaining a strong track record of quality compliance. Tressa's contributions have been recognized within the industry, and she is frequently invited to speak at prominent pharmaceutical conferences and events.
Conclusion
With her extensive experience, strong technical expertise, and proven leadership skills, Tressa Randall is a valuable asset to Faraday Pharmaceuticals. Her dedication to ensuring the safety and efficacy of pharmaceutical products, coupled with her ability to navigate the evolving regulatory environment, position her as a respected and influential figure in the pharmaceutical industry.
